Cfra Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €68.00 Price Target

Cfra set a €68.00 ($79.07) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report released on Friday morning. The brokerage currently has a neutral rating on the stock.

Several other research analysts also recently commented on FME. Goldman Sachs Group set a €98.00 ($113.95) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Friday, August 24th. HSBC set a €107.00 ($124.42) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Tuesday, August 28th. JPMorgan Chase & Co. set a €97.90 ($113.84) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Wednesday, August 29th. Barclays set a €87.20 ($101.40) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Friday, August 31st. Finally, UBS Group set a €86.00 ($100.00) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Friday, August 31st. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company currently has a consensus rating of Buy and a consensus target price of €87.36 ($101.59).

FME opened at €62.24 ($72.37) on Friday. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €75.53 ($87.83) and a 52 week high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Further Reading: What is a Candlestick Chart?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply